Apr 4, 2024, 07:37 AM by

Universal Brain Expands Executive Team to Accelerate Precision Psychiatry

Apr 4, 2024, 07:37 AM by

Apr 3, 2024, 07:56 AM by

Peerbridge Health’s Remote Device for Early Detection of Heart Failure Achieves 95.7% Success Rate in Trial

Apr 3, 2024, 07:56 AM by

Lindus Health Unveils Versatile “All-in-One Respiratory CRO” Offering Tailored to Respiratory Clinical Trials

Apr 3, 2024, 07:56 AM by

Scope of Industry Risk-Based Quality Management (RBQM) Adoption Revealed CluePoints, the Tufts Center for the Study of Drug Development and PwC publish Comprehensive Assessment of RBQM Adoption in Clinical Trials.

Apr 3, 2024, 06:00 AM by User Not Found

Bio-IT World | The single biggest risk factor for autoimmune disease is being biologically a female and many explanations have been proposed as to why that is, among them sex hormones and the X chromosome with its large number of immune-related genes.

Apr 2, 2024, 07:53 AM by

The RSA Group, a leading life sciences executive search firm, has published the latest of its Talent Equity Reports: “Sustaining a winning position” – an analysis of how Switzerland can continue to lead the life sciences sector in a shifting global market.

Apr 2, 2024, 06:00 AM by User Not Found

Bio-IT World | Miguel Edwards, a partner at DeciBio Consulting, broke down the market outlook for spatial biology at last week’s Precision Medicine TriConference. “We think about this market really as opening up a new dimension of biological insight into tissue analysis,” Edwards said. “You’re seeing the excitement and promise for really improving our understanding of fundamental biology and really driving better therapeutics and better diagnostics.”

Mar 28, 2024, 08:05 AM by

Global genomics solutions provider Integrated DNA Technologies (IDT) is expanding its gene synthesis offerings with a new custom vector onboarding tool.

Mar 28, 2024, 08:05 AM by

Mar 28, 2024, 06:00 AM by User Not Found

Bio-IT World | In the newest episode of Trends from the Trenches, host Stan Gloss speaks with La Barge about his unique perspective on growing biotech businesses. La Barge delves into the challenges he and his team face in gene therapy advancement and how a company—especially one just starting out—can pave the path to successful research.

Mar 27, 2024, 06:36 AM by

One2Treat launches groundbreaking treatment-decision approach to clinical research and market access analysis One2Treat reflects patient priorities in a single comprehensive treatment evaluation, reducing trial sample size and accelerating patient access to new treatments

Mar 27, 2024, 06:36 AM by

Mar 27, 2024, 06:36 AM by

New ready-to-launch formulation range features premium branded ingredients, and targets issues as diverse as PMS, fertility, prenatal & postnatal care and menopause wellbeing.

Mar 27, 2024, 06:00 AM by User Not Found

Bio-IT World | PacBio announced the PureTarget repeat expansion panel, a new solution designed to enable the comprehensive analysis of 20 genes associated with serious neurological disorders; Owkin and Sanofi take on immunology; new products from Beckman Coulter, Arrayjet, and PatientSight; and more.

Mar 26, 2024, 08:03 AM by

CluePoints, providers of best-in-class statistical and AI-driven software solutions, has been shortlisted as finalist for the Best Sponsor-facing Technology Initiative in the 2024 Citeline Awards. CluePoints was recognized for its Site Profile & Oversight Tool (SPOT), - due to launch to the market in June 2024 – and was developed collaboratively, based on market needs, with two large pharmaceutical clients of CluePoints who helped provide direction and feedback regarding the required features and functionalities.

Mar 26, 2024, 08:03 AM by

Phastar, a global specialist biometrics contract research organization (CRO), has been selected as finalist for the Best Sponsor-facing Technology Initiative at the Citeline Awards 2024. Phastar were recognised for the launch of their Clinical Intelligence Portal, and notably the comprehensive recruitment forecasting app within that suite.

Mar 26, 2024, 08:03 AM by

Watson-Marlow Fluid Technology Solutions (WMFTS) will preview two new technologies at booth 3521 during INTERPHEX 2024, 16-18th April 2024, Javits Center, NYC, USA.

Mar 26, 2024, 06:00 AM by User Not Found

Bio-IT World | Capstan Therapeutics is advancing CPTX2309, their lead in vivo chimeric antigen receptor T cell (CAR-T) candidate, to early clinical proof-of-concept in autoimmune disorders; Clasp is developing modular T cell engagers tailored to each patient’s immune system that are directed to common oncogenic driver mutations, resulting in off-the-shelf, antibody-like medicines that can specifically target a wide variety of hard-to-treat tumor types; Ultrahuman plan to further manufacture capacity and deepen research in the health tracking space; and more.

Mar 25, 2024, 06:21 AM by